Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon

Daily Archives November 7, 2020

Four-year results from patient-level meta-analysis confirm safety ...

November 07, 2020 Meta-analysis of two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today […]Read More

Four-year results from patient-level meta-analysis confirm safety ...

November 07, 2020 Meta-analysis of two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today […]Read More

Britain Begins COVID Mass Testing in Liverpool

LONDON - As Britain battles a surge in coronavirus infections with a nationwide monthlong lockdown, an ambitious mass testing pilot project has been launched in the northwestern city of Liverpool. Anyone who lives or works in the city and comes forward...Read More

Britain Begins COVID Mass Testing in Liverpool

LONDON - As Britain battles a surge in coronavirus infections with a nationwide monthlong lockdown, an ambitious mass testing pilot project has been launched in the northwestern city of Liverpool. Anyone who lives or works in the city and comes forward...Read More